← Open Payments lookup

JENNA COOPER: Open Payments

NPI 1790883429 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,946 in 87 payments from 36 companies in 2025. Trend: 2023 $1,791 · 2024 $2,291 · 2025 $1,946

Food & beverage: $1,876Education: $70
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$207
ABBVIE INC.7$167
HARMONY BIOSCIENCES LLC7$151
Merz Pharmaceuticals, LLC4$115
Biogen, Inc.6$114
JAZZ PHARMACEUTICALS INC.5$92
Alexion Pharmaceuticals, Inc.3$82
Takeda Pharmaceuticals U.S.A., Inc.3$76
UCB, Inc.3$74
PFIZER INC.3$71

Products named: INGREZZA, Xeomin, LEQEMBI, ULTOMIRIS, BOTOX, WAKIX, HYQVIA, Rystiggo.

Industry payments across AL — which companies pay providers there.